Aggressive Lymphoma | List of Frontiers open access articles

Original Research

Published on 31 Jul 2023

Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma

in Cancer Immunity and Immunotherapy

Maria Patra-Kneuer
Gaomei Chang
Wendan Xu
Christian Augsberger
Michael Grau
Myroslav Zapukhlyak
Kristina Ilieva
Karin Landgraf
Doris Mangelberger-Eberl
Kasra Yousefi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1220558

8,069 views
6 citations

Case Report

Published on 14 Jul 2021

Successful Chimeric Antigen Receptor (CAR) T-Cell Treatment in Aggressive Lymphoma Despite Coronavirus Disease 2019 (CoVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication - Case Report

in Hematologic Malignancies

Verena Nilius-Eliliwi
Thomas Mika
Alexander Baraniskin
Max Wünnenberg
Marina Maslova
Christian Boy
Susanne Klein-Scory
Roland Schroers
Deepak Vangala

Frontiers in Oncology

doi 10.3389/fonc.2021.706431

5,093 views
2 citations

Review

Published on 22 Mar 2022

Biology and Treatment of Richter Transformation

in Hematologic Malignancies

Adalgisa Condoluci
Davide Rossi

Frontiers in Oncology

doi 10.3389/fonc.2022.829983

20,626 views
50 citations

Original Research

Published on 07 Apr 2025

Abnormally high expression of CHI3L1 in peripheral blood mononuclear cells and serum and their potential diagnosis and prediction from lymphoma patients

in Cancer Immunity and Immunotherapy

Chao Wang
Langui Tang
Haibing Luo
Juan Liang
Yanzhao Huang
Kaiyun Guo
Rong Liu
Yuxing He
Yan Gao
Ming Lei

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557802

2,520 views
1 citation

Original Research

Published on 17 Sep 2025

Cognitive impairment and brain atrophy in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy: a normative analysis

in Applied Neuroimaging

Charlotte Ditchfield
Priscilla Gates
Juan F Domínguez D
Haryana M. Dhillon
Vincent Dore
Carlene Wilson
Karen Caeyenberghs

Frontiers in Neurology

doi 10.3389/fneur.2025.1601459

1,980 views
1 citation

Mini Review

Published on 13 Oct 2022

NOTCH1 Signalling: A key pathway for the development of high-risk chronic lymphocytic leukaemia

in Hematologic Malignancies

Jennifer Edelmann

Frontiers in Oncology

doi 10.3389/fonc.2022.1019730

7,387 views
6 citations

Case Report

Published on 06 Feb 2026

Case Report: Targeting the Achilles’ heel of monomorphic epitheliotropic intestinal T-cell lymphoma

in Hematologic Malignancies

Song Xue
Hong-fei Gu
Fan Yang
Wei Zhang
Xi-yang Liu
Hui-peng Sun
Xing-yu Cao

Frontiers in Oncology

doi 10.3389/fonc.2026.1710764

651 views

Case Report

Published on 02 Oct 2020

Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report

in Hematologic Malignancies

Dennis Christoph Harrer
Karin Menhart
Stephanie Mayer
Wolfgang Herr
Albrecht Reichle
Martin Vogelhuber

Frontiers in Oncology

doi 10.3389/fonc.2020.585830

6,984 views
1 citation

Original Research

Published on 19 Feb 2019

Capsaicin Induces Apoptosis in KSHV-Positive Primary Effusion Lymphoma by Suppressing ERK and p38 MAPK Signaling and IL-6 Expression

in Cancer Molecular Targets and Therapeutics

Misato Moriguchi
Tadashi Watanabe
Ayano Kadota
Masahiro Fujimuro

Frontiers in Oncology

doi 10.3389/fonc.2019.00083

5,147 views
24 citations

Original Research

Published on 06 Aug 2020

Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma

in Hematologic Malignancies

Xue-wen Zhang
Xi-wen Bi
Pan-pan Liu
Ze-long Liu
Man Nie
Hang Yang
De-xin Lei
Yi Xia
Wen-qi Jiang
Wei-an Zeng

Frontiers in Oncology

doi 10.3389/fonc.2020.01360

6,689 views
15 citations

Original Research

Published on 13 Jun 2018

A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis

in Virology

Mattia Vicario
Adriana Mattiolo
Barbara Montini
Maria Assunta Piano
Ilaria Cavallari
Alberto Amadori
Luigi Chieco-Bianchi
Maria Luisa Calabrò

Frontiers in Microbiology

doi 10.3389/fmicb.2018.01215

8,652 views
8 citations

Original Research

Published on 02 Oct 2025

Ibrutinib combined with rituximab and high-dose methotrexate in newly diagnosed primary CNS diffuse large B-cell lymphoma: a pilot study with long-term follow-up

in Hematologic Malignancies

Yixian Guo
Yongzhi Shan
Yueshan Piao
Xiaoli Chang
Dongmei Zou
Qiang Ma
Yukui Wei
Geng Xu
Yaming Wang
Dandan Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1669385

3,313 views

Review

Published on 14 Dec 2020

Microenvironment Remodeling and Subsequent Clinical Implications in Diffuse Large B-Cell Histologic Variant of Richter Syndrome

in Cancer Immunity and Immunotherapy

Hélène Augé
Anne-Béatrice Notarantonio
Romain Morizot
Anne Quinquenel
Luc-Matthieu Fornecker
Sébastien Hergalant
Pierre Feugier
Julien Broséus

Frontiers in Immunology

doi 10.3389/fimmu.2020.594841

8,185 views
21 citations

Original Research

Published on 15 Jul 2022

RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma

in Pharmacology of Anti-Cancer Drugs

Cong Xu
Ting Liang
Jing Liu
Yunfeng Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.931501

12,948 views
10 citations

Original Research

Published on 18 Jul 2022

A Multicenter Study of 239 Patients Aged Over 70 Years With Diffuse Large B-Cell Lymphoma in China

in Pharmacology of Anti-Cancer Drugs

Chunli Yang
Qiaoer Li
Ke Xie
Yakun Zhang
Dania Xiang
Yunwei Han
Liqun Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.953808

3,443 views

Mini Review

Published on 27 May 2020

Primary Cutaneous B-Cell Lymphomas: An Update

in Hematologic Malignancies

Paola Vitiello
Antonello Sica
Andrea Ronchi
Stefano Caccavale
Renato Franco
Giuseppe Argenziano

Frontiers in Oncology

doi 10.3389/fonc.2020.00651

36,740 views
97 citations

Articles

Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma

Successful Chimeric Antigen Receptor (CAR) T-Cell Treatment in Aggressive Lymphoma Despite Coronavirus Disease 2019 (CoVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication - Case Report

Biology and Treatment of Richter Transformation

Abnormally high expression of CHI3L1 in peripheral blood mononuclear cells and serum and their potential diagnosis and prediction from lymphoma patients

Cognitive impairment and brain atrophy in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy: a normative analysis

NOTCH1 Signalling: A key pathway for the development of high-risk chronic lymphocytic leukaemia

Case Report: Targeting the Achilles’ heel of monomorphic epitheliotropic intestinal T-cell lymphoma

Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report

Capsaicin Induces Apoptosis in KSHV-Positive Primary Effusion Lymphoma by Suppressing ERK and p38 MAPK Signaling and IL-6 Expression

Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma

A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis

Ibrutinib combined with rituximab and high-dose methotrexate in newly diagnosed primary CNS diffuse large B-cell lymphoma: a pilot study with long-term follow-up

Microenvironment Remodeling and Subsequent Clinical Implications in Diffuse Large B-Cell Histologic Variant of Richter Syndrome

RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma

A Multicenter Study of 239 Patients Aged Over 70 Years With Diffuse Large B-Cell Lymphoma in China

Primary Cutaneous B-Cell Lymphomas: An Update